Cypress Bioscience
Genomic Tests Firm Exagen Buying Cypress’ Dx Biz
Exagen will pay Cypress up to $8 million in upfront and milestone payments as well as additional royalty payments for the business.
Under the deal, Marina will receive $750,000 up front, and stands to be paid as much as $27 million in milestones.
Cypress Bioscience Test Gets Positive Medicare Reimbursement Decision
The firm offers its Avise PG test as a service for physicians making decisions about methotrexate therapy.
Cypress Acquires Personalized Medicine Technology from Cellatope
Cypress will pay up to $5 million for the technology, which it plans to use for diagnosis and therapeutic monitoring of lupus patients.